FDA Inspection 672696 — Novartis Pharma Schweizerhalle Ag
The FDA completed an inspection of Novartis Pharma Schweizerhalle Ag on Jul 9, 2010 in Pratteln. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 9, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Pratteln (Switzerland)